Stimcell Energetics (STME) Assets Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 35.44% |
| Nov 30, 2025 | 29.64% |
| Aug 31, 2025 | -16.92% |
| May 31, 2025 | -19.93% |
| Feb 28, 2025 | -32.20% |
| Nov 30, 2024 | -19.16% |
| Aug 31, 2024 | -39.65% |
| May 31, 2024 | -4.07% |
| Feb 29, 2024 | -6.45% |
| Nov 30, 2023 | -38.36% |
| Aug 31, 2023 | -36.07% |
| May 31, 2023 | -13.43% |
| Feb 28, 2023 | -60.45% |
| Nov 30, 2022 | -60.94% |
| Aug 31, 2022 | -60.11% |
| May 31, 2022 | -39.91% |
| Feb 28, 2022 | -37.23% |
| Nov 30, 2021 | -8.63% |
| Aug 31, 2021 | 25.16% |
| May 31, 2021 | 4.90% |
| Feb 28, 2021 | -14.96% |
| Nov 30, 2020 | -36.20% |
| Aug 31, 2020 | -23.47% |
| May 31, 2020 | -18.47% |
| Feb 29, 2020 | -12.48% |
| May 31, 2019 | -10.85% |
| May 31, 2017 | 525.37% |
| May 31, 2016 | 190.42% |
| May 31, 2014 | 313.39% |